3,854 reports of this reaction
8.1% of all ESZOPICLONE reports
#3 most reported adverse reaction
DYSGEUSIA is the #3 most commonly reported adverse reaction for ESZOPICLONE, manufactured by Waylis Therapeutics LLC. There are 3,854 FDA adverse event reports linking ESZOPICLONE to DYSGEUSIA. This represents approximately 8.1% of all 47,350 adverse event reports for this drug.
Patients taking ESZOPICLONE who experience dysgeusia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DYSGEUSIA is moderately reported among ESZOPICLONE users, representing a notable but not dominant share of adverse events.
In addition to dysgeusia, the following adverse reactions have been reported for ESZOPICLONE:
The following drugs have also been linked to dysgeusia in FDA adverse event reports:
DYSGEUSIA has been reported as an adverse event in 3,854 FDA reports for ESZOPICLONE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DYSGEUSIA accounts for approximately 8.1% of all adverse event reports for ESZOPICLONE, making it one of the most commonly reported side effect.
If you experience dysgeusia while taking ESZOPICLONE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.